Patents by Inventor Bernd Kuttler

Bernd Kuttler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MEDICAL IMPLANTS CONTAINING FK506 (TACROLIMUS) METHODS OF MAKING AND METHODS OF USE THEREOF
    Publication number: 20120239139
    Abstract: Implants and methods of making same are provided for treatment or prophylaxis of coronary or peripheral vascular constrictions or vascular occlusions, and particularly, stenoses or restenoses, that comprise FK506 in chemically covalently bound, non-covalently bound or physically immobilized form.
    Type: Application
    Filed: May 25, 2012
    Publication date: September 20, 2012
    Applicants: ASTELLAS PHARMA INC., ABBOTT LABORATORIES VASCULAR ENTREPRISES LTD.
    Inventors: Stephan Wnendt, Randolf Von Oepen, Bernd Kuttler, Gerhard Lang, Guenter Lorenz, Axel Grandt
  • Medical implants containing FK506 (tacrolimus)
    Patent number: 8187320
    Abstract: Implants and methods of making same are provided for treatment or prophylaxis of coronary or peripheral vascular constrictions or vascular occlusions, and particularly, stenoses or restenoses, that comprise FK506 in chemically covalently bound, non-covalently bound or physically immobilized form.
    Type: Grant
    Filed: August 15, 2003
    Date of Patent: May 29, 2012
    Assignees: Abbott Laboratories Vascular Enterprises Limited, Astellas Pharma Inc.
    Inventors: Stephan Wnendt, Randolf Von Oepen, Bernd Kuttler, Gerhard Lang, Guenter Lorenz, Axel Grandt
  • Implants containing combretastatin a-4
    Publication number: 20050065595
    Abstract: The subject matter of this invention relates to implants, in particular intracavernous or intravascular implants, preferably for use in the treatment or prophylaxis of coronary or peripheral vascular occlusions or vascular narrowings or stenoses, in particular for use in the prophylaxis of a restenosis, which implants contain CA4 or CA4P in a chemically covalently or noncovalently bonded or a physically fixed form, and methods for the production and application thereof.
    Type: Application
    Filed: September 3, 2002
    Publication date: March 24, 2005
    Inventors: David Chaplin, Stephan Wnendt, Bernd Kuttler, Gunter Lorenz
  • Medical implants containing FK506 (tacrolimus), methods of making and methods of use thereof
    Publication number: 20040117008
    Abstract: Implants and methods of making same are provided for treatment or prophylaxis of coronary or peripheral vascular constrictions or vascular occlusions, and particularly, stenoses or restenoses, that comprise FK506 in chemically covalently bound, non-covalently bound or physically immobilized form.
    Type: Application
    Filed: August 15, 2003
    Publication date: June 17, 2004
    Applicants: Abbott Laboratories Vascular Enterprises Ltd., Fujisawa Pharmaceutical Company, Ltd.
    Inventors: Stephan Wnendt, Randolf Von Oepen, Bernd Kuttler, Gerhard Lang, Guenter Lorenz, Axel Grandt